National Health Investors Inc (NHI) Stock Forecast & Price Target
National Health Investors Inc · NYSE
$71.42+0.54 (+0.76%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering National Health Investors Inc, 4 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $78.00 to $94.00, so the covering firms are broadly aligned. The average target of $83.50 sits 17% above the current $71.42. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.67 next quarter toward $3.25 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy467%
Hold233%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to National Health Investors Inc.
As of Sep, 4 of 6 firms rate NHI a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NHI EPS & revenue forecast
EPS · NEXT QUARTER
$2.67
Range $0.79 – $4.55 · 2 analysts · +252% YoY
Next period, 2 analysts expect National Health Investors Inc to earn $2.67 a share (range $0.79 – $4.55), versus $0.76 a year earlier. Full-year consensus is $14.55, growing to $3.25 the year after.
REVENUE · NEXT QUARTER
$112.8M
Range $108.2M – $120.8M · 2 analysts · +7% YoY
Revenue is expected to reach $112.8M (range $108.2M – $120.8M), +6.6% year-over-year. Full-year consensus is $456.5M, rising to $477.0M next year.
Top analysts covering National Health Investors Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NHI.
#1
John Kilichowski
Wells Fargo · Rank #116
Hold
$78.00+9.2% to target
Overall win rate
46%
+ Follow
#2
Michael Lewis
Truist Securities · Rank #187
Buy
$81.00+13.4% to target
Overall win rate
42%
+ Follow
#3
Omotayo Okusanya
Deutsche Bank
Hold
$80.00+12.0% to target
Coverage
—
+ Follow
#4
FG
Farrell Granath
Bank of America Securities
Buy
$91.00+27.4% to target
Coverage
—
+ Follow
#5
Richard Anderson
Cantor Fitzgerald
Buy
$94.00+31.6% to target
Coverage
—
+ Follow
NHI stock forecast FAQ
What is NHI's average 12-month price target?+
The 6 analysts with a live target average $83.50 for National Health Investors Inc over the next 12 months, ranging from a $94.00 high to a $78.00 low.
Is NHI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 4 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NHI?+
The Street-high target is $94.00 (Cantor Fitzgerald), and the Street-low is $78.00 (Wells Fargo). The average of all 6 active targets is $83.50.
How many Wall Street analysts cover NHI?+
6 analysts have an active rating on National Health Investors Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering NHI?+
Among analysts who currently cover NHI, John Kilichowski of Wells Fargo has the strongest overall Quantellect track record (Rank #116). Their current call is Hold with a $78.00 target.
What is National Health Investors Inc's projected EPS for next quarter?+
The consensus estimate is $2.67 per share (range $0.79 – $4.55) across 2 analysts. Full-year EPS is projected at $14.55, rising to $3.25 the following year.
How much revenue is National Health Investors Inc expected to report next quarter?+
Consensus revenue is $112.8M (range $108.2M – $120.8M). Full-year revenue is projected at $456.5M, growing to $477.0M next year.
Have analysts been upgrading or downgrading NHI lately?+
As of Sep, 4 of 6 firms rate NHI a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NHI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
